Publication Title ("Obesity, Fitness & Wellness Week") And Id (0IHH) And Date (Apr 09, 2022) - Results

Select Findings from IRCCS Ospedale Policlinico San Martino Broaden Understanding of Thyroid Cancer (2-[F-18]Fdg Pet In the Management of Radioiodine Refractory Differentiated Thyroid Cancer In the Era of Thyrosin-kinases Inhibitors: a Real-life ...)

1

Findings from IRCCS Ospedale Policlinico San Martino Broaden Understanding of Thyroid Cancer (2-[F-18]Fdg Pet In the Management of Radioiodine Refractory Differentiated Thyroid Cancer In the Era of Thyrosin-kinases Inhibitors: a Real-life ...)

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022445 words Article 1160L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Thyroid Cancer have been published. According to news reporting originating in Genoa,...

Select Findings from University of Manitoba Provides New Data about Extracellular Matrix Proteins [Tenascin C Is Dysregulated In Hypoplastic Lungs of Mir-200b(-/-) Mice].

2

Findings from University of Manitoba Provides New Data about Extracellular Matrix Proteins [Tenascin C Is Dysregulated In Hypoplastic Lungs of Mir-200b(-/-) Mice].

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022480 words Report 1340L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Proteins - Extracellular Matrix Proteins. According to news reporting originating...

Select Findings from University of Florida Yields New Findings on Cancer (Cell-intrinsic View of the Aryl Hydrocarbon Receptor In Tumor Immunity).

3

Findings from University of Florida Yields New Findings on Cancer (Cell-intrinsic View of the Aryl Hydrocarbon Receptor In Tumor Immunity).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022376 words Brief article 1350L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Cancer. According to news reporting out of Gainesville, Florida, by NewsRx editors,...

Select Cerevel Therapeutics Holdings, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 18, 2022).

4

Cerevel Therapeutics Holdings, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 18, 2022).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022239 words Brief article 1190L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange...

Select Cancer Hospital Researchers Describe Advances in Autoimmunity (PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases).

5

Cancer Hospital Researchers Describe Advances in Autoimmunity (PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022344 words Report, Brief articl... 1330L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on autoimmunity. According to news reporting from Beijing, People's Republic of China,...

Select Axsome Therapeutics, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 17, 2022).

6

Axsome Therapeutics, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 17, 2022).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022242 words Brief article 1190L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange...

Select Cymabay Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Mar. 17, 2022).

7

Cymabay Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Mar. 17, 2022).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022211 words Brief article 1100L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange...

Select Support needs of people living with obesity during transition from tertiary obesity treatment to community care.

8

Support needs of people living with obesity during transition from tertiary obesity treatment to community care.

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022371 words Brief article 1370L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained the following quote sourced from...

Select Data from Faculty of Sciences Advance Knowledge in Tissue Engineering (Antibacterial Nanocomposite Supporting Cell Growth and Spheroid Formation By Chemical Surface Treatment of Polymer Foil).

9

Data from Faculty of Sciences Advance Knowledge in Tissue Engineering (Antibacterial Nanocomposite Supporting Cell Growth and Spheroid Formation By Chemical Surface Treatment of Polymer Foil).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022447 words Report 1330L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Biomedical Engineering - Tissue Engineering are discussed in a new report. According to news...

Select Aldeyra Therapeutics, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Mar. 17, 2022).

10

Aldeyra Therapeutics, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Mar. 17, 2022).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022179 words Brief article 1040L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange...

Select Analysis of alternative mRNA splicing in vemuraf-enib-resistant melanoma cells.

11

Analysis of alternative mRNA splicing in vemuraf-enib-resistant melanoma cells.

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022273 words Brief article 1310L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained the following quote sourced from...

Select African Palliative Care Association Researchers Describe Recent Advances in Cancer ().

12

African Palliative Care Association Researchers Describe Recent Advances in Cancer ().

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022449 words Report 1430L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on cancer. According to news reporting out of Kampala, Uganda, by NewsRx editors,...

Select New Drug Delivery Systems Findings from National University of Colombia Reported [Recent Progress In Self-emulsifying Drug Delivery Systems: a Systematic Patent Review (2011-2020)].

13

New Drug Delivery Systems Findings from National University of Colombia Reported [Recent Progress In Self-emulsifying Drug Delivery Systems: a Systematic Patent Review (2011-2020)].

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022406 words Article 1450L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Drugs and Therapies - Drug Delivery Systems. According to news reporting originating from...

Select New Findings from Amirkabir University of Technology in the Area of Molecular Liquids Described (Capability of Mxene 2d Material As an Amoxicillin, Ampicillin, and Cloxacillin Adsorbent In Wastewater).

14

New Findings from Amirkabir University of Technology in the Area of Molecular Liquids Described (Capability of Mxene 2d Material As an Amoxicillin, Ampicillin, and Cloxacillin Adsorbent In Wastewater).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022412 words Article 1150L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Molecular Liquids. According to news reporting originating from Tehran, Iran, by NewsRx...

Select New Findings Reported from Guizhou Normal University Describe Advances in Cancer (Development of 5-trifluoromethylpyrimidine Derivatives As Dual Inhibitors of Egfr and Src for Cancer Therapy).

15

New Findings Reported from Guizhou Normal University Describe Advances in Cancer (Development of 5-trifluoromethylpyrimidine Derivatives As Dual Inhibitors of Egfr and Src for Cancer Therapy).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022399 words Report, Brief articl... 1420L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Cancer is the subject of a report. According to news reporting originating from Guiyang, People's...

Select New Data from Yangzhou University Illuminate Findings in Nanoparticles (A Core-shell Insulin/cs-plga Nanoparticle for Enhancement of Oral Insulin Bioavailability: In Vitro and In Vivo Study).

16

New Data from Yangzhou University Illuminate Findings in Nanoparticles (A Core-shell Insulin/cs-plga Nanoparticle for Enhancement of Oral Insulin Bioavailability: In Vitro and In Vivo Study).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022413 words Report 1630L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Nanotechnology - Nanoparticles. According to news originating from Jiangsu, People's...

Select New Findings on Cancer Described by Investigators at Xiangtan University (Atp-responsive Near-infrared Fluorescent Nanoparticles for Synergistic Chemotherapy and Starvation Therapy).

17

New Findings on Cancer Described by Investigators at Xiangtan University (Atp-responsive Near-infrared Fluorescent Nanoparticles for Synergistic Chemotherapy and Starvation Therapy).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022505 words Article 1490L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Cancer have been presented. According to news originating from Xiangtan, People's Republic of China, by...

Select New Findings from Yunnan University in Leukemia Provides New Insights [Spiroarborin, an Ent-clerodane Homodimer From Callicarpa Arborea As an Inhibitor of the Eleven-nineteen Leukemia (Enl) Protein By the Yeats Domain].

18

New Findings from Yunnan University in Leukemia Provides New Insights [Spiroarborin, an Ent-clerodane Homodimer From Callicarpa Arborea As an Inhibitor of the Eleven-nineteen Leukemia (Enl) Protein By the Yeats Domain].

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022450 words Article 1550L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Leukemia have been published. According to news reporting originating in Yunnan,...

Select Janux Therapeutics, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Mar. 18, 2022).

19

Janux Therapeutics, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Mar. 18, 2022).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022193 words Brief article 980L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange...

Select Investigators from Loyola University Chicago Release New Data on Kinase Inhibitors (Integrin Subunit Beta 8 Contributes To Lenvatinib Resistance In Hcc).

20

Investigators from Loyola University Chicago Release New Data on Kinase Inhibitors (Integrin Subunit Beta 8 Contributes To Lenvatinib Resistance In Hcc).

From:Obesity, Fitness & Wellness Week

Apr. 9, 2022423 words Report 1350L2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Drugs and Therapies - Kinase Inhibitors are discussed in a new report. According to news reporting...

Open Access User

Library Information

Showing Results for

Search Results

Academic Journals

Findings from IRCCS Ospedale Policlinico San Martino Broaden Understanding of Thyroid Cancer (2-[F-18]Fdg Pet In the Management of Radioiodine Refractory Differentiated Thyroid Cancer In the Era of Thyrosin-kinases Inhibitors: a Real-life ...)

Findings from University of Manitoba Provides New Data about Extracellular Matrix Proteins [Tenascin C Is Dysregulated In Hypoplastic Lungs of Mir-200b(-/-) Mice].

Findings from University of Florida Yields New Findings on Cancer (Cell-intrinsic View of the Aryl Hydrocarbon Receptor In Tumor Immunity).

Cerevel Therapeutics Holdings, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 18, 2022).

Cancer Hospital Researchers Describe Advances in Autoimmunity (PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases).

Axsome Therapeutics, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 17, 2022).

Cymabay Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Mar. 17, 2022).

Support needs of people living with obesity during transition from tertiary obesity treatment to community care.

Data from Faculty of Sciences Advance Knowledge in Tissue Engineering (Antibacterial Nanocomposite Supporting Cell Growth and Spheroid Formation By Chemical Surface Treatment of Polymer Foil).

Aldeyra Therapeutics, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Mar. 17, 2022).

Analysis of alternative mRNA splicing in vemuraf-enib-resistant melanoma cells.

African Palliative Care Association Researchers Describe Recent Advances in Cancer ().

New Drug Delivery Systems Findings from National University of Colombia Reported [Recent Progress In Self-emulsifying Drug Delivery Systems: a Systematic Patent Review (2011-2020)].

New Findings from Amirkabir University of Technology in the Area of Molecular Liquids Described (Capability of Mxene 2d Material As an Amoxicillin, Ampicillin, and Cloxacillin Adsorbent In Wastewater).

New Findings Reported from Guizhou Normal University Describe Advances in Cancer (Development of 5-trifluoromethylpyrimidine Derivatives As Dual Inhibitors of Egfr and Src for Cancer Therapy).

New Data from Yangzhou University Illuminate Findings in Nanoparticles (A Core-shell Insulin/cs-plga Nanoparticle for Enhancement of Oral Insulin Bioavailability: In Vitro and In Vivo Study).

New Findings on Cancer Described by Investigators at Xiangtan University (Atp-responsive Near-infrared Fluorescent Nanoparticles for Synergistic Chemotherapy and Starvation Therapy).

New Findings from Yunnan University in Leukemia Provides New Insights [Spiroarborin, an Ent-clerodane Homodimer From Callicarpa Arborea As an Inhibitor of the Eleven-nineteen Leukemia (Enl) Protein By the Yeats Domain].

Janux Therapeutics, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Mar. 18, 2022).

Investigators from Loyola University Chicago Release New Data on Kinase Inhibitors (Integrin Subunit Beta 8 Contributes To Lenvatinib Resistance In Hcc).

Filter Your Results